PubMed · 1993 · 10 citations · 0 references
MedicineEmergency MedicineSurgeryHemostasisTransfusion MedicineVascular SurgeryAcute Gastrointestinal HemorrhageAnticoagulant ManagementGastrointestinal BleedingGastrointestinal Bleeding ManagementGastrointestinal EndoscopyHemorrhage ControlActive Bleeding DetectionBleedingBlood Transfusion TherapyEmergency EndoscopyEmergency Upper Gastrointestinal EndoscopyEndoscopic Injection TherapyGastrointestinal Bleeding SurgeryManagement Of Bleeding Complications
One hundred and ninety-one patients who had emergency endoscopy performed for acute gastroduodenal haemorrhage and were found to be bleeding actively (N = 141) or to have an ulcer containing a non-bleeding visible vessel (N = 50) were studied. Patients with active bleeding were divided into two groups: group I included 47 patients in whom diagnostic endoscopy was performed and conventional management applied; and group II contained 94 patients in whom, apart from conventional treatment, endoscopic thrombin injections could also be offered. Fifty patients with non-bleeding visible vessels were admitted to a prospective randomised trial and assigned to either endoscopic injections (group A, N = 25), or no primary endoscopic treatment (group B, N = 25). The introduction of the injection therapy in patients who were actively bleeding resulted in a significant reduction of the emergency operation rate (70.2% v. 12.8%; P < 0.001), mortality rate (21.3% v. 8.5%; P < 0.05 and blood transfusion requirements (4,220 +/- 1,840 ml v. 1,980 +/- 980 ml; P < 0.05). Endoscopic thrombin injections of non-bleeding visible vessels reduced the rebleeding rate (40% v. 4%; P < 0.01) and blood transfusions (2,939 +/- 1070 ml v. 1,390 +/- 552 ml; P < 0.05).